Drug Approval | October 02, 2024
SMS Pharma receives EDQM certification to supply Ibuprofen in Europe
The inspection conducted by EDQM at its Visakhapatnam facility
The inspection conducted by EDQM at its Visakhapatnam facility
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
This approval reflects company’s unwavering commitment that the quality assurance
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
The inspection was concluded with two 483 observations
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Subscribe To Our Newsletter & Stay Updated
